51st week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200390821 | MODULATION OF SPLENOCYTES IN CELL THERAPY | 2020-12-17 |
20200390822 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING SEPSIS AND/OR INFLAMMATORY CONDITIONS | 2020-12-17 |
20200390823 | FREE-STANDING, TRANSFERRABLE VASCULAR NETWORKS VIA GUIDED SELF-ASSEMBLY AND USE IN CELL REPLACEMENT THERAPIES | 2020-12-17 |
20200390824 | Umbilical Tissue Compositions and Methods of Use | 2020-12-17 |
20200390825 | PLURIPOTENT STEM CELL-DIRECTED MODEL OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE FOR DISEASE MECHANISM AND DRUG DISCOVERY | 2020-12-17 |
20200390826 | THERAPEUTIC OR NON-THERAPEUTIC USE OF PROTOZOANS OF THE WILLAERTIA GENUS AS A FUNGISTATIC AND/OR FUNGICIDE | 2020-12-17 |
20200390827 | PORPHYROMONAS GINGIVALIS IMMUNE MODULATORS AND USES THEREOF | 2020-12-17 |
20200390828 | LIPOPOLYSACCHARIDE-REGULATED ENTERIC BACTERIA AND USE THEREOF | 2020-12-17 |
20200390829 | PROBIOTICS AND PROBIOTIC COMPOSITIONS FOR REGULATING BODY WEIGHT | 2020-12-17 |
20200390830 | SYSTEMS AND METHODS FOR TREATING A DYSBIOSIS USING FECAL-DERIVED BACTERIAL POPULATIONS | 2020-12-17 |
20200390831 | Probiotic | 2020-12-17 |
20200390832 | COMPOSITION FOR USE IN THE TREATMENT AND/OR IMPROVEMENT OF SLEEP AND MOOD DISORDERS | 2020-12-17 |
20200390833 | FASTING-MIMICKING DIET (FMD) BUT NOT WATER-ONLY FASTING PROMOTES REVERSAL OF INFLAMMATION AND IBD PATHOLOGY | 2020-12-17 |
20200390834 | PROBIOTICS AND FERMENTATION METABOLITES FOR THE PREVENTION AND TREATMENT OF DISEASE CONDITIONS IN ANIMALS | 2020-12-17 |
20200390835 | Composition and a method for inhibiting the growth of pathogens causing bovine liver abscesses | 2020-12-17 |
20200390836 | SEASONED LAVER INCLUDING HEMP OIL AND MANUFACTURING METHOD THEREOF | 2020-12-17 |
20200390837 | INGESTIBLE FILMS HAVING SUBSTANCES FROM HEMP OR CANNABIS | 2020-12-17 |
20200390838 | APPARATUS AND METHOD FOR EXTRACTION AND DECARBOXYLATION OF PHYTOCANNABINOIDS | 2020-12-17 |
20200390839 | METHOD FOR TREATING BENIGN PROSTATIC HYPERPLASIA (BPH) | 2020-12-17 |
20200390840 | METHOD FOR SEPARATING EIGHT COMPONENTS IN CHINESE TRADITIONAL MEDICINE COMPOSITION | 2020-12-17 |
20200390841 | COMPOSITIONS AND METHODS FOR TREATING WOUNDS | 2020-12-17 |
20200390842 | COMPOSITION FOR ALLEVIATING SKIN INFLAMMATION CAUSED BY YELLOW DUST AND FINE PARTICULATE, COMPRISING NATURAL PLANT EXTRACT | 2020-12-17 |
20200390843 | SUSTAINED RELEASE FORMULATIONS OF CROCUS SATIVUS | 2020-12-17 |
20200390844 | PAIN RELIEVING SYSTEM | 2020-12-17 |
20200390845 | PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR | 2020-12-17 |
20200390846 | PEPTIDE CAPABLE OF IMPROVING COGNITIVE FUNCTION | 2020-12-17 |
20200390847 | METHOD OF TREATING DISEASES | 2020-12-17 |
20200390848 | Methods of Treating Wounds Using Cathepsin K Inhibitors | 2020-12-17 |
20200390849 | Pharmaceutical Compositions having a Selected Release Duration | 2020-12-17 |
20200390850 | PEPTIDES AND USES THEREOF | 2020-12-17 |
20200390851 | VIRAL TREATMENT | 2020-12-17 |
20200390852 | COMPOSITIONS AND METHODS FOR TREATING PERIPHERAL NERVE DISEASE, DISORDERS, AND INJURIES | 2020-12-17 |
20200390853 | ACTIVE PEPTIDE FOR ENHANCING THE PHAGOCYTIC FUNCTIONS OF RETINAL PIGMENT EPITHELIUM AND A USE THEREOF | 2020-12-17 |
20200390854 | STIMULATION OF HAIR GROWTH BY SENESCENT CELLS AND SENESCENCE ASSOCIATED SECRETORY PHENOTYPE | 2020-12-17 |
20200390855 | COMPOSITIONS, ARTICLES OF MANUFACTURE AND METHODS FOR TREATING CANCER | 2020-12-17 |
20200390856 | METHODS OF TREATING AUTOIMMUNE DISEASE | 2020-12-17 |
20200390857 | METHOD FOR INCREASING NEPRILYSIN EXPRESSION AND ACTIVITY | 2020-12-17 |
20200390858 | Combination Therapy for Modulating Bile Acid Homeostasis and Treatment of Bile Acid Disorders and Diseases | 2020-12-17 |
20200390859 | METHODS FOR TREATMENT OF BILE ACID-RELATED DISORDERS | 2020-12-17 |
20200390860 | COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION | 2020-12-17 |
20200390861 | IL-4-FUSION FORMULATIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS | 2020-12-17 |
20200390862 | Treatment of Short Bowel Syndrome Patients with Colon-in-Continuity | 2020-12-17 |
20200390863 | THERAPEUTIC PEGYLATED GROWTH HORMONE ANTAGONISTS | 2020-12-17 |
20200390864 | Novel Polymeric hGH Prodrugs | 2020-12-17 |
20200390865 | FUSION PROTEINS | 2020-12-17 |
20200390866 | FACTOR VIII SEQUENCES | 2020-12-17 |
20200390867 | SUPER-OXIDE DISMUTASE SOLUBLE FIBER COMPOSITIONS | 2020-12-17 |
20200390868 | ANTI-VIRAL THERAPEUTIC FOR INFECTION OF THE EYE | 2020-12-17 |
20200390869 | RUSALATIDE ACETATE COMPOSITIONS | 2020-12-17 |
20200390870 | HUMANIZED ANTI-MUC1* ANTIBODIES AND DIRECT USE OF CLEAVAGE ENZYME | 2020-12-17 |
20200390871 | BOTULINUM TOXIN FORMULATIONS AND METHODS OF USE THEREOF IN PLANTAR FASCITIS WITH EXTENDED DURATION OF EFFECT | 2020-12-17 |
20200390872 | Treatment and prevention of pre-eclampsia | 2020-12-17 |
20200390873 | NEOANTIGEN IMMUNOTHERAPIES | 2020-12-17 |
20200390874 | YEAST-BASED IMMUNOTHERAPY AND TYPE I INTERFERON SENSITIVITY | 2020-12-17 |
20200390875 | DRIED COMPOSITION | 2020-12-17 |
20200390876 | METHODS OF TUMOR VACCINATION | 2020-12-17 |
20200390877 | FORMULATIONS OF DENGUE VIRUS VACCINE COMPOSITIONS | 2020-12-17 |
20200390878 | RECOMBINANT SWINEPOX VIRUS AND VACCINES | 2020-12-17 |
20200390879 | HUMAN JAPANESE ENCEPHALITIS VIRUS ANTIBODIES AND METHODS OF USE THEREFOR | 2020-12-17 |
20200390880 | Filovirus Consensus Antigens, Nucleic Acid Constructs And Vaccines Made Therefrom, And Methods Of Using Same | 2020-12-17 |
20200390881 | NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE | 2020-12-17 |
20200390882 | ALPHA-HELICAL PEPTIDE NANOFIBERS AS A SELF-ADJUVANTING VACCINE PLATFORM | 2020-12-17 |
20200390883 | NOVEL ADJUVANT FOR ANIMAL AND HUMAN VACCINES | 2020-12-17 |
20200390884 | Methods and Compositions for Modulating AKT3 | 2020-12-17 |
20200390885 | METHODS FOR ENHANCING ANTIGEN-SPECIFIC IMMUNE RESPONSES | 2020-12-17 |
20200390886 | SELECTIVELY ALTERING MICROBIOTA FOR IMMUNE MODULATION | 2020-12-17 |
20200390887 | COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER | 2020-12-17 |
20200390888 | NOVEL AAV MEDIATED INFLUENZA VACCINES | 2020-12-17 |
20200390889 | REMOTELY TRIGGERED THERAPY | 2020-12-17 |
20200390890 | ANTIBACTERIAL PHOTODYNAMIC THERAPY USING COPPER-CYSTEAMINE NANOPARTICLES | 2020-12-17 |
20200390891 | POLYMER-BASED SUSTAINED RELEASE DEVICE | 2020-12-17 |
20200390892 | Tamper Resistant Pharmaceutical Formulations | 2020-12-17 |
20200390893 | SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID | 2020-12-17 |
20200390894 | PROTEOLYSIS-TARGETING CHIMERIC MOLECULES (PROTACS) THAT INDUCE DEGRADATION OF C-MYC PROTEIN | 2020-12-17 |
20200390895 | UNIVERSAL ABT COMPOUNDS AND USES THEREOF | 2020-12-17 |
20200390896 | Polyamine Prodrugs And Polyamine Prodrug Formulations | 2020-12-17 |
20200390897 | Oral Gene Carrier And Use Thereof | 2020-12-17 |
20200390898 | KNOTTIN-DRUG CONJUGATES AND METHODS OF USING THE SAME | 2020-12-17 |
20200390899 | AMINOBENZAZEPINE COMPOUNDS, IMMUNOCONJUGATES, AND USES THEREOF | 2020-12-17 |
20200390900 | ANTI-CDH6 ANTIBODY AND ANTI-CDH6 ANTIBODY-DRUG CONJUGATE | 2020-12-17 |
20200390901 | CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONOTHIOLATES AND - PHOSPHONATES | 2020-12-17 |
20200390902 | Antibody-Drug Conjugates Targeted at Human Aspartyl-(Asparaginyl)-B-Hydroxylase (HAAH) | 2020-12-17 |
20200390903 | PLECTIN-TARGETED LIPOSOMES/PARP INHIBITOR IN THE TREATMENT OF CANCER | 2020-12-17 |
20200390904 | ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES AS RADIO-SENSITIZERS AND MRI AND/OR X-RAY CONTRAST AGENTS | 2020-12-17 |
20200390905 | COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT | 2020-12-17 |
20200390906 | COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING NEUROINFLAMMATION, NEURODEGENERATION, NEUROPATHIC PAIN, AND MIGRAINE | 2020-12-17 |
20200390907 | METHODS AND COMPOSITIONS FOR TREATING GENETICALLY LINKED DISEASES OF THE EYE | 2020-12-17 |
20200390908 | Metal Nanoparticles and Methods of Making Same | 2020-12-17 |
20200390909 | DRUG FRAGMENT IMAGING AGENT CONJUGATES | 2020-12-17 |
20200390910 | PROCESS FOR PRODUCING A CONTRAST AGENT | 2020-12-17 |
20200390911 | LIPID ENCAPSULATED GAS MICROSPHERE COMPOSITIONS AND RELATED METHODS | 2020-12-17 |
20200390912 | EVALUATION OF PRESENCE OF AND VULNERABILITY TO ATRIAL FIBRILLATION AND OTHER INDICATIONS USING MATRIX METALLOPROTEINASE-BASED IMAGING | 2020-12-17 |
20200390913 | RADIOLABELED PROGASTRIN IN CANCER DIAGNOSIS | 2020-12-17 |
20200390914 | METHOD FOR LABELING RADIOISOTOPE, RADIOLABELING COMPOUNDS USING QUINONE COMPOUND AND KIT COMPRISING THE SAME FOR LABELING RADIOISOTOPE | 2020-12-17 |
20200390915 | BACTERIAL LIGHT SOURCE WITH HIGH QUALITY OF LIGHT | 2020-12-17 |
20200390916 | METHOD FOR MIXING AND DISPENSING | 2020-12-17 |
20200390917 | MOBILE PHONE SANITIZATION DEVICE | 2020-12-17 |
20200390918 | SANITIZATION DEVICE FOR FOOTWEAR | 2020-12-17 |
20200390919 | ANTIMICROBIAL AGENT CONTAINING HYPOCHLOROUS ACID | 2020-12-17 |
20200390920 | METHOD, SYSTEM AND DEVICE FOR REDUCING MICROBIAL CONCENTRATION AND/OR BIOFILM FORMATION AND/OR REDUCING MINERAL AND CHEMICAL CONCENTRATIONS TO PURIFY CONTAMINATED SURFACES AND SUBSTANCES | 2020-12-17 |